|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2025
vol. 127 Review article
Risk of herpes simplex keratitis recurrence after ocular surgeries
Piotr Kanclerz
1
,
Katarzyna Przewłócka
1
KLINIKA OCZNA 2025, 127, 2: 62-70
Online publish date: 2025/06/23
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Smith JS, Jamie Robinson N. Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review. J Infect Dis 2002; 186: S3-28. 2.
Tsatsos M, MacGregor C, Athanasiadis I, et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents – comment. Clin Experiment Ophthalmol 2017; 45: 932. 3.
Dawson CR, Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 1976; 21: 121-135. 4.
Cunningham AL, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 2006; 194 Suppl 1: S11-S18. 5.
Ribaric V. The Incidence of Herpetic Keratitis among Population. Ophthalmologica 1976; 173: 19-22. 6.
Liesegang TJ. Epidemiology of Ocular Herpes Simplex. Arch Ophthalmol 1989; 107: 1155. 7.
Labetoulle M, Auquier P, Conrad H, et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 2005; 112: 888-895. 8.
Shuster JJ, Kaufman HE, Nesburn AB. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol 1981; 91: 328-331. 9.
Barker NH. Ocular herpes simplex. BMJ Clin Evid 2008; 2008: 0707. 10.
Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol 2009; 54: 226-234. 11.
Barequet IS, Wasserzug Y. Herpes simplex keratitis after cataract surgery. Cornea 2007; 26: 615-617. 12.
Zhang S, Mi J, Ge S, Wang G, et al. Analysis of clinical characteristics and factors influencing herpes simplex virus keratitis. Front Med 2023; 10: 1267783. 13.
Chen H-F, Yeung L, Yang K-J, Sun C-C. Persistent corneal epithelial defect after pars plana vitrectomy. Retina 2016; 36: 148-155. 14.
Jain V, Pineda R. Reactivated herpetic keratitis following laser in situ keratomileusis. J Cataract Refract Surg 2009; 35: 946-948. 15.
Jabbur NS, O’Brien TP. Recurrence of keratitis after excimer laser keratectomy. J Cataract Refract Surg 2003; 29: 198-201. 16.
Rezende RA, Uchoa UBC, Raber IM, et al. New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol 2004; 137: 415-419. 17.
Kessel L, Tendal B, Jorgensen KJ, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 2014; 121: 1915-1924. 18.
Simone JN, Whitacre MM. Effects of anti-inflammatory drugs following cataract extraction. Current Opinion in Opthalmology 2001; 12: 63-67. 19.
Funk CD. Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology. Science 2001; 294: 1871-1875. 20.
Comstock TL, Decory HH. Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate. Int J Inflam 2012; 2012: 789623. 21.
Baker DA, Thomas J. The effect of prostaglandin E2 on the initial immune response to herpes simplex virus infection. Am J Obstet Gynecol 1985; 151: 586-590. 22.
Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis. Ophthalmology 2020; 127: S5-S18. 23.
Kaufman HE, Varnell ED, Thompson HW. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol 1999; 127: 531-536. 24.
Qi X, Wang M, Li X, et al. Characteristics of New Onset Herpes Simplex Keratitis after Keratoplasty. J Ophthalmol 2018; 2018: 4351460. 25.
Cook SD, Paveloff MJ, Doucet JJ, et al. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci 1991; 32: 1558-1561. 26.
Cheng H, Tumpey TM, Staats HF, et al. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci 2000; 41: 1402-1409. 27.
Li J, Ma H, Zhao Z, et al. Deep anterior lamellar keratoplasty using precut anterior lamellar cap for herpes simplex keratitis: a long-term follow-up study. Br J Ophthalmol 2014; 98: 448-453. 28.
Rock D, Lokensgard J, Lewis T, Kutish G. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J Virol 1992; 66: 2484-2490. 29.
Yang AY, Chow J, Liu J. Corneal Innervation and Sensation: The Eye and Beyond. Yale J Biol Med 2018; 91: 13-21. 30.
Cho YK, Kwon JW, Konda S, Ambati BK. Epithelial Keratitis After Cataract Surgery. Cornea 2018; 37: 755-759. 31.
Rosenthal P, Borsook D, Moulton EA. Oculofacial Pain: Corneal Nerve Damage Leading to Pain Beyond the Eye. Invest Opthamol Vis Sci 2016; 57: 5285. 32.
Beyer CF, Hill JM, Reidy JJ, Beuerman RW. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest Ophthalmol Vis Sci 1990; 31: 925-932. 33.
Tal-Singer R, Lasner TM, Podrzucki W, et al. Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 1997; 71: 5268-5276. 34.
Toma HS, Murina AT, Areaux RG, et al. Ocular HSV-1 Latency, Reactivation and Recurrent Disease. Semin Ophthalmol 2008; 23: 249-273. 35.
Dhaliwal DK, Romanowski EG, Yates KA, et al. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am J Ophthalmol 2001; 131: 506-507. 36.
Wilcox CL, Johnson EM Jr. Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol 1987; 61: 2311-2315. 37.
Kanclerz P, Alió JL. Ocular surgery after herpes simplex and herpes zoster keratitis. Int Ophthalmol 2020; 40: 3599-3612. 38.
Sawtell NM, Thompson RL. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 1992; 66: 2150-2156. 39.
Laycock KA, Lee SF, Brady RH, Pepose JS. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest Ophthalmol Vis Sci 1991; 32: 2741-2746. 40.
Brunsmann U, Sauer U, Arba-Mosquera S, et al. Evaluation of thermal load during laser corneal refractive surgery using infrared thermography. Infrared Physics & Technology 2010; 53: 342-347. 41.
De Ortueta D, Arba-Mosquera S, Magnago T. High-speed recording of thermal load during laser trans-epithelial corneal refractive surgery using a 750 Hz ablation system. J Optom 2019; 12: 84-91. 42.
Grinde B. Herpesviruses: latency and reactivation – viral strategies and host response. J Oral Microbiol 2013; 5: 22766. 43.
Padgett DA, Sheridan JF, Dorne J, et al. Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci U S A 1998; 95: 7231-7235. 44.
Kobayashi M, Wilson AC, Chao MV, Mohr I. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. Genes Dev 2012; 26: 1527-1532. 45.
Al-Dujaili LJ, Clerkin PP, Clement C, et al. Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol 2011; 6: 877-907. 46.
Chaloulis SK, Mousteris G, Tsaousis KT. Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update. Trop Med Infect Dis 2022; 7: 92. 47.
Predictors of Recurrent Herpes Simplex Virus Keratitis. Cornea 2001; 20: 123-128. 48.
Shtayer C, Friehmann A, Nemet A. New-Onset of Herpes Simplex Keratitis After Blepharoplasty, Case Series and Review of the Literature. Ophthal Plast Reconstr Surg 2023; 39: 614-616. 49.
Daher ND, Syed ZA. Bilateral interstitial keratitis following COVID-19: a case report. BMC Ophthalmol 2023; 23: 414. 50.
Lee TE, Ahn SH, Jeong CY, et al. Herpesviral Keratitis Following COVID-19 Vaccination: Analysis of NHIS Database in Korea. Cornea 2024; 44: 168-179. 51.
Ghosh S, Jhanji V, Lamoureux E, et al. Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am J Ophthalmol 2008; 145: 198-202. 52.
Halberstadt M, Machens M, Gahlenbek KA, et al. The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin. Br J Ophthalmol 2002; 86: 646-652. 53.
Goodfellow JFB, Nabili S, Jones MNA, et al. Antiviral treatment following penetrating keratoplasty for herpetic keratitis. Eye 2011; 25: 470-474. 54.
Barney NP, Foster CS. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 1994; 13: 232-236. 55.
Awan MA, Roberts F, Hegarty B, Ramaesh K. The outcome of deep anterior lamellar keratoplasty in herpes simplex virus-related corneal scarring, complications and graft survival. Br J Ophthalmol 2010; 94: 1300-1303. 56.
Shimizu E, Yamaguchi T, Tomida D, et al. Corneal Higher-order Aberrations and Visual Improvement Following Corneal Transplantation in Treating Herpes Simplex Keratitis. Am J Ophthalmol 2017; 184: 1-10. 57.
Ogawa A, Yamaguchi T, Mitamura H, et al. Aetiology-specific comparison of long-term outcome of deep anterior lamellar keratoplasty for corneal diseases. Br J Ophthalmol1 2016; 100: 1176-1182. 58.
Wu S-Q, Zhou P, Zhang B, et al. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis. Am J Ophthalmol 2012; 153: 291-299.e2. 59.
Lyall DAM, Tarafdar S, Gilhooly MJ, et al. Long term visual outcomes, graft survival and complications of deep anterior lamellar keratoplasty in patients with herpes simplex related corneal scarring. Br J Ophthalmol 2012; 96: 1200-1203. 60.
Lu LM, McGhee CNJ, Sims JL, Niederer RL. High rate of recurrence of herpes zoster-related ocular disease after phacoemulsification cataract surgery. J Cataract Refract Surg 2019; 45: 810-815. 61.
He Y, de Melo Franco R, Kron-Gray MM, et al. Outcomes of cataract surgery in eyes with previous herpes zoster ophthalmicus. J Cataract Refract Surg 2015; 41: 771-777. 62.
Silva MV de R, de Rojas Silva MV, et al. Prophylactic Perioperative Antiviral Therapy for LASIK in Patients With Inactive Herpetic Keratitis. J Refract Surg 2006; 22: 404-406. 63.
Jarade EF, Tabbara KF. Laser in situ keratomileusis in eyes with inactive herpetic keratitis. Am J Ophthalmol 2001; 132: 779-780. 64.
Altay Y, Tamer S, Kaya AS, et al. The outcome of penetrating keratoplasty for corneal scarring due to herpes simplex keratitis. Arq Bras Oftalmol 2017; 80: 41-45. 65.
Goldblum D, Bachmann C, Tappeiner C, et al. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis. Br J Ophthalmol 2008; 92: 1201-1205. 66.
Liu X, Zhou Q, Huang X, et al. Clinical evaluation of deep anterior lamellar keratoplasty using glycerol-cryopreserved corneal tissues for refractory herpetic stromal keratitis: An observational study. Medicine 2016; 95: e4892. 67.
Ren Y, Wang H, Zheng Q, et al. Long-Term Outcomes of Deep Anterior Lamellar Keratoplasty Treating Posterior Stroma-Implicated Herpetic Corneal Opacities. Cornea 2016; 35: 299-304. 68.
Katragadda S, Gunda S, Hariharan S, Mitra AK. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int J Pharm 2008; 359: 15-24. 69.
Sarnicola V, Toro P. Deep anterior lamellar keratoplasty in herpes simplex corneal opacities. Cornea 2010; 29: 60-64. 70.
Leccisotti A. Air-assisted manual deep anterior lamellar keratoplasty for treatment of herpetic corneal scars. Cornea 2009; 28: 728-731. 71.
Jansen AFG, Rijneveld WJ, Remeijer L, et al. Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. Cornea 2009; 28: 843-845. 72.
Garcia DD, Farjo Q, Musch DC, Sugar A. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 2007; 26: 930-934. 73.
de Rojas Silva V, Rodriguez-Conde R, Cobo-Soriano R, et al. Laser in situ keratomileusis in patients with a history of ocular herpes. J Cataract Refract Surg 2007; 33: 1855-1859. 74.
van Rooij J, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo controlled multicenter trial. Ophthalmology 2003; 110: 1916-1919. 75.
Tambasco FP, Cohen EJ, Nguyen LH, et al. Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis. Arch Ophthalmol 1999; 117: 445. 76.
Akova YA, Onat M, Duman S. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex keratitis. Ocul Immunol Inflamm 1999; 7: 51-60. 77.
Fagerholm P, Ohman L, Orndahl M. Phototherapeutic keratectomy in herpes simplex keratitis. Clinical results in 20 patients. Acta Ophthalmol 1994; 72: 457-460. 78.
Garcia DD, Farjo Q, Musch DC, Sugar A. Effect of Prophylactic Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis. Cornea 2007; 26: 930-934. 79.
Hung SO, Patterson A, Rees PJ. Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol 1984; 68: 192-195. 80.
Gessa-Sorroche M, Kanclerz P, Alio JL. Evidence in the prevention of the recurrence of herpes simplex and herpes zoster keratitis after eye surgery. Arch Soc Esp Oftalmol (Engl Ed) 2022; 97: 149-160. 81.
Crumpacker CS, Schnipper LE, Zaia JA, Levin MJ. Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother 1979; 15: 642-645. 82.
Schulman J, Peyman GA, Fiscella R, et al. Intraocular acyclovir levels after subconjunctival and topical administration. Br J Ophthalmol 1986; 70: 138-140. 83.
Wilhelmus KR, Beck RW, Moke PS, et al. Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease. New Eng J Med 1998; 339: 300-306. 84.
Gold D, Corey L. Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother 1987; 31: 361-367. 85.
Moshirfar M, Kelkar N, Peterson T, et al. The Impact of Antiviral Resistance on Herpetic Keratitis. Eye Contact Lens 2023; 49: 127-134. 86.
Venugopal A, Christy J, Raut V, et al. Viral Keratitis, Surgical Intervention in Viral Keratitis, Challenges in Diagnosis and Treatment of Viral Keratitis, HSV, HZV. Semin Ophthalmol 2024; 39: 340-352.
|
POLSKI
